ProfileGDS4132 / 206619_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 39% 46% 31% 31% 40% 41% 36% 52% 26% 30% 20% 21% 20% 24% 20% 19% 21% 19% 19% 21% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101102.3739
GSM201543Muscle PCOS pioglitazone 121112.75346
GSM201544Muscle PCOS pioglitazone 16180.45531
GSM201545Muscle PCOS pioglitazone 20184.388131
GSM201829Muscle PCOS pioglitazone 231110.36540
GSM201830Muscle PCOS pioglitazon 251111.74541
GSM201831Muscle PCOS pioglitazone 27192.235236
GSM201832Muscle PCOS pioglitazone 31135.98752
GSM201833Muscle PCOS pioglitazone 4157.211526
GSM201834Muscle PCOS pioglitazone 8170.200130
GSM201835Muscle PCOS after pioglitazone 10233.51120
GSM201836Muscle PCOS after pioglitazone 12238.171221
GSM201837Muscle PCOS after pioglitazone 16233.733220
GSM201838Muscle PCOS after pioglitazone 20248.890724
GSM201839Muscle PCOS after pioglitazone 23238.385920
GSM201840Muscle PCOS after pioglitazone 25240.704319
GSM201841Muscle PCOS after pioglitazone 27235.607621
GSM201842Muscle PCOS after pioglitazone 3232.436119
GSM201843Muscle PCOS after pioglitazone 4241.96719
GSM201844Muscle PCOS after pioglitazone 8243.043821